CC BY 4.0 · TH Open 2019; 03(04): e350-e355
DOI: 10.1055/s-0039-3400483
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Reliability and Feasibility of the Self-Administered ISTH-Bleeding Assessment Tool

Marieke C. Punt
1   Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
,
Maaike W. Blaauwgeers
1   Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
,
Merel A. Timmer
1   Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
,
Paco M.J. Welsing
2   Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
,
Roger E.G. Schutgens
1   Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
,
Karin P.M. van Galen
1   Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
› Author Affiliations
Further Information

Publication History

09 August 2019

11 October 2019

Publication Date:
29 November 2019 (online)

Abstract

Introduction Standardized bleeding assessment tools (BATs), such as the International Society for Thrombosis and Hemostasis (ISTH)-BAT, are screening instruments used during the diagnostic workup of suspected bleeding disorders. A self-administered ISTH-BAT (self-BAT) would enhance screening and save time during an outpatient clinic visit.

Aim This study was aimed to investigate the reliability and feasibility of the self-BAT.

Methods The electronic self-BAT was created from the ISTH-BAT and paper-version of self-BAT and optimized by patients and physicians. Patients with a (suspected) congenital platelet defect (CPD), who had previously undergone physician-administered ISTH-BAT assessment, were invited to complete the self-BAT. Optimal self-BAT cut-off values to detect a bleeding tendency, as defined by the ISTH-BAT, were evaluated by receiver operator characteristic (ROC) curve analysis to reach a sensitivity ≥95%. Reliability was tested by assessing sensitivity, specificity, and intraclass correlation (ICC). Feasibility was evaluated on comprehension and length of self-BAT.

Results Both versions of the BAT were completed by 156 patients. Optimal cut-off values for self-BAT to define a bleeding tendency were found to be identical to those of the ISTH-BAT. Normal/abnormal scores of the ISTH-BAT and self-BAT were agreed in 88.5% (138/156, 95% confidence interval [CI]: 0.83–0.93) of patients. The sensitivity and specificity of the self-BAT to detect a bleeding tendency were 96.9 and 48.1%, respectively. The ICC was 0.73. Self-BAT questions were graded by 96.8% (151/156) as “very easy,” “easy,” and “satisfactory” and questionnaire length as “exactly right” by 91% (142/156) of patients.

Conclusion In patients with a (suspected) CPD, the self-BAT is sufficiently reliable and feasible to detect a bleeding tendency, which supports its use as a screening tool.

Supplementary Material

 
  • References

  • 1 Castaman G, Linari S. Diagnosis and treatment of von Willebrand disease and rare bleeding disorders. J Clin Med 2017; 6 (04) 45
  • 2 Rydz N, James P. The evolution and value of bleeding assessment tools. J Thromb Haemost 2012; 10: 2223-2229
  • 3 Rodeghiero F, Tosetto A, Abshire T. , et al; ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8 (09) 2063-2065
  • 4 Rashid A, Moiz B, Karim F, Shaikh MS, Mansoori H, Raheem A. Use of ISTH bleeding assessment tool to predict inherited platelet dysfunction in resource constrained settings. Scand J Clin Lab Invest 2016; 76 (05) 373-378
  • 5 Lowe GC, Lordkipanidzé M, Watson SP. ; UK GAPP study group. Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. J Thromb Haemost 2013; 11 (09) 1663-1668
  • 6 Moenen FCJI, Nelemans PJ, Schols SEM, Schouten HC, Henskens YMC, Beckers EAM. The diagnostic accuracy of bleeding assessment tools for the identification of patients with mild bleeding disorders: A systematic review. Haemophilia 2018; 24 (04) 525-535
  • 7 Deforest M, Grabell J, Albert S. , et al. Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease. Haemophilia 2015; 21 (05) e384-e388
  • 8 Blaauwgeers M, van Asten I, Huisman A. , et al. Laboratory characterization of patients with (suspected) inherited platelet disorders: results form the ‘Thrombocytopathy in the Netherlands’ study. Hematol Educ 2018; 215916: PS1405
  • 9 Elbatarny M, Mollah S, Grabell J. , et al; Zimmerman Program Investigators. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia 2014; 20 (06) 831-835
  • 10 Stokhuijzen E, Rand ML, Cnossen MH. , et al. Identifying Children with HEreditary Coagulation disorders (iCHEC): a protocol for a prospective cohort study. BMJ Open 2018; 8 (05) e020686
  • 11 Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016; 15 (02) 155-163